Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review
Clinical Nutrition ESPEN · 2025
DOI: 10.1016/j.clnesp.2024.11.032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Nutrition ESPEN, 2025. Verfasst von Matin Sepehrinia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute (WHO Collaborating Center), Shahid Behes…. Hauptthemen laut MEDLINE: Inflammation, Diet, Fatty Liver, Metabolic Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Metabolic (dysfunction)-associated steatotic liver disease (MASLD) represents a spectrum of liver pathologies linked to metabolic syndrome components. Inflammation emerges as a pivotal player in MASLD pathogenesis, initiating and perpetuating hepatic injury. Diet, a modifiable risk factor, influences inflammation levels and MASLD progression. This review synthesizes existing evidence on the association between pro-inflammatory diets, assessed via the Dietary Inflammatory Index (DII) and Empirical Dietary Inflammatory Potential (EDIP), and MASLD. Evidence suggests a significant association between higher DII/EDIP scores and MASLD risk, with studies revealing a positive correlation between inflammatory diet intake and MASLD occurrence, particularly in males. However, inconsistencies exist regarding the influence of body mass index (BMI) on this association and criticisms regarding adjustment for BMI and reliance on surrogate markers necessitate cautious interpretation. Limited data suggest a potential link between dietary inflammatory potential and advanced liver fibrosis and heightened risk of hepatocellular carcinoma (HCC) with increased DII/EDIP scores, albeit requiring further confirmation through gold-standard assessment methods. Dietary-induced inflammation exacerbates MASLD pathogenesis through multiple pathways, including insulin resistance, adipose tissue dysfunction, gut microbiota alterations, and oxidative stress, culminating in hepatic steatosis, inflammation, and fibrosis. Further research utilizing robust methodologies is imperative to confirm these findings and elucidate underlying mechanisms, thus informing targeted dietary interventions for MASLD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute (WHO Collaborating Center), Shahid Beheshti University of Medical Sciences, Tehran, Iran; Student Research Com…
- Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran, Iran; University of Medical Sciences, Tehran, Iran; School of Medicine, Tehran University of Medical Science…
- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: rezaei_nima@tums.ac.ir.
- Division of Endocrinology and Diabetes, Medanta The Medicity, Gurugram 122001, Haryana, India. Electronic address: drshafikuchay@gmail.com.
Zitieren
APA
Sepehrinia, M., Khanmohammadi, S., Rezaei, N., & Kuchay, M. S. (2025). Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2024.11.032
Vancouver
Sepehrinia M, Khanmohammadi S, Rezaei N, Kuchay MS. Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review. Clinical Nutrition ESPEN. 2025. doi:10.1016/j.clnesp.2024.11.032
BibTeX
@article{Sepehrinia2025,
author = {Sepehrinia, Matin and Khanmohammadi, Shaghayegh and Rezaei, Nima and Kuchay, Mohammad Shafi},
title = {Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review},
journal = {Clinical Nutrition ESPEN},
year = {2025},
doi = {10.1016/j.clnesp.2024.11.032}
}
EUVIMED